European Immunology

Immunotherapy

Immunotherapy represents a transformative approach in treating diseases by leveraging the body's immune system to target and eliminate abnormal cells, such as cancer cells or those involved in autoimmune disorders. It encompasses various strategies, including immune checkpoint inhibitors (e.g., PD-1/PD-L1 blockers), which unleash the immune system's ability to recognize and destroy cancer cells; adoptive cell therapies like CAR-T cells, where patient's T cells are engineered to target specific cancer antigens; and cytokine therapies that enhance immune responses. Immunotherapy has revolutionized cancer treatment, offering durable responses, fewer side effects compared to traditional therapies like chemotherapy, and potential applications in treating autoimmune diseases and infectious diseases.